HIGHLIGHTS
- who: Rituximab em doenu00e7as glomerulares from the (UNIVERSITY) have published the research work: O a | a O, in the Journal: (JOURNAL)
- what: The study provided significant insight on the use of RTX in different GD and suggests a differential response to rituximab therapy, which may provide the background for future pathophysiology studies.
- how: The study was conducted in a single center and was retrospective which are important limitations.
SUMMARY
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.